Abbott Laboratories

ABTUS — S&P 100Balanced

↓ Hajras full report

Overvalued

Current price88.67USD

Fair value (est., median)52.36USD

UndervaluedFair valueOvervalued

+69.3% above fair valueWould need to fall ~40.9% to reach fair value.

Health Check

47.7

Overall / 100

Good (66+)Caution (40–65)Risk (<40)

Value0/100

Trades about 69.4% above its estimated fair value.

Discount to fair value: -69.3%
Price to book: 2.96×
Fair-value confidence: —

Future40/100

Modest growth of about 8% a year is expected.

Forecast growth (rev.): 8%
Revenue CAGR (18y): 3%
Earnings CAGR (18y): —

Past64.5/100

A steady, profitable operating history.

Return on equity: 12.5%
Net margin: 14.7%
Earnings CAGR (18y): —
Profitable years: 15/19

Health81.1/100

Balance sheet is manageable.

Debt to equity: 26.6%
Net debt to equity: 10.2%
Cash covers total debt: No
Free cash flow: Positive

Dividend53/100

Yields 2.67%, paying out 63.1% of earnings.

Dividend yield: 2.67%
Payout ratio: 63.1%
Covered by free cash flow: Yes
Years paying: 19
Dividend growth: —

Rewards

Healthy balance sheet.

Risks

Trades 69.4% above estimated fair value.

Scores are computed automatically from the real financial statements (Value from fair value; the rest from growth, profitability, balance sheet and dividends). A decision aid, not investment advice.

Price, corporate actions & news

Demo series

Daily MA

Weekly MA

D — DividendS — Split▲ good · ▼ bad newstap a marker for details

Growth & profitability

Revenue, net income and margin.

RevenueNet incomeNet margin %tap a bar for figures

Key figures

Metric	FY'21	FY'22	FY'23	FY'24	FY'25
Revenue	43.08B	43.65B	40.11B	41.95B	44.33B
Net Income	7.07B	6.93B	5.72B	13.40B	6.52B
Net Margin	16.4%	15.9%	14.3%	31.9%	14.7%
Operating Cash Flow	10.53B	9.58B	7.26B	8.56B	9.57B
OCF Margin	24.5%	21.9%	18.1%	20.4%	21.6%
Capital Expenditure	1.89B	1.78B	2.20B	2.21B	2.17B
Free Cash Flow	8.65B	7.80B	5.06B	6.35B	7.39B
FCF Margin	20.1%	17.9%	12.6%	15.1%	16.7%
FCF Conversion	122.3%	112.6%	88.4%	47.4%	113.4%
EPS (Diluted)	4.06/sh	3.98/sh	3.29/sh	7.69/sh	3.75/sh
Dividend / Share	1.84/sh	1.90/sh	2.04/sh	2.20/sh	2.36/sh

Dividend return (if you buy today)if you buy today

Dividend yield2.67%

Dividend / share2.36 USD

If you invest

USD

Shares (≈)112

Est. annual income264.67 USD

At this rate, dividends alone return your capital in ~37.5 years.

Dividend history

Dividend / share & historical yield (USD).

Dividend / share yield %tap a bar for figures

Quarterly dividends & yield

Per-share dividends by quarter, full-year total, and yield on the year's average price · USD

Year	Q1	Q2	Q3	Q4	Full year	Yield (avg)
2026	—	0.63	—	—	0.63	0.7%
2025	—	—	—	—	2.36	1.8%
2024	—	—	—	—	2.20	1.9%
2023	0.51	0.51	0.51	0.51	2.04	1.9%
2022	0.47	0.47	0.47	0.47	1.90	1.8%
2021	0.45	0.45	0.45	0.45	1.84	1.5%
2020	0.36	0.36	0.36	0.36	1.47	1.4%
2019	0.32	0.32	0.32	0.32	1.30	1.6%
2018	0.28	0.28	0.28	0.28	1.13	1.6%
2017	0.27	0.27	0.27	0.27	1.06	2.0%
2016	—	—	—	—	0.88	2.1%
2015	—	—	—	—	0.83	1.9%
2014	—	—	—	—	0.77	1.8%
2013	0.14	0.14	0.14	0.14	0.51	1.4%
2012	—	—	—	—	1.83	5.8%
2011	—	—	—	—	1.69	6.5%
2010	—	—	—	—	1.53	6.7%
2009	—	—	—	—	1.39	5.8%
2008	—	—	—	—	1.25	4.9%
2007	—	—	—	—	1.12	4.3%
2006	0.13	0.14	0.14	0.14	0.55	2.4%
2005	0.12	0.13	0.13	0.13	0.51	2.4%
2004	0.11	1.49	0.12	0.12	1.84	9.0%
2003	0.11	0.11	0.11	0.11	0.44	2.3%
2002	0.09	0.11	0.11	0.11	0.42	2.2%
2001	0.09	0.09	0.09	0.09	0.36	1.5%
2000	0.08	0.09	0.09	0.09	0.35	1.7%
1999	0.07	0.08	0.08	0.08	0.31	1.7%
1998	0.06	0.07	0.07	0.07	0.27	1.4%
1997	0.11	0.06	0.06	0.06	0.29	2.0%
1996	0.05	0.05	0.05	0.05	0.20	1.8%
1995	0.04	0.05	0.05	0.05	0.19	2.1%
1994	0.04	0.04	0.04	0.04	0.16	2.2%
1993	0.03	0.04	0.04	0.04	0.15	2.4%
1992	0.03	0.03	0.03	0.03	0.12	1.8%
1991	0.02	0.03	0.03	0.03	0.11	1.7%
1990	0.02	0.02	0.02	0.02	0.08	1.7%
1989	0.02	0.02	0.02	0.02	0.08	2.2%
1988	0.01	0.02	0.02	0.02	0.07	2.6%
1987	0.01	0.01	0.01	—	0.03	1.0%
1986	0.01	0.01	0.01	0.01	0.04	1.4%
1985	0.01	0.01	0.01	0.01	0.04	2.3%
1984	0.01	0.01	0.01	0.01	0.04	3.0%
1983	—	0.01	0.01	0.01	0.03	—

Corporate actions

DCash Dividend

0.63 USD /sh2026-04-15

DCash Dividend

0.55 USD /sh2024-07-15

DCash Dividend

0.55 USD /sh2024-04-12

DCash Dividend

0.55 USD /sh2024-01-11

DCash Dividend

0.51 USD /sh2023-10-12

DCash Dividend

0.51 USD /sh2023-07-13

DCash Dividend

0.51 USD /sh2023-04-13

DCash Dividend

0.51 USD /sh2023-01-12

DCash Dividend

0.47 USD /sh2022-10-13

DCash Dividend

0.47 USD /sh2022-07-14

Shariah compliance

Compliant

AAOIFI-style financial screens on the latest annual figures.

Business activityPermissible sector

Interest-bearing debt / market cap

9.0% · cap 30%

Pass

Cash & securities / market cap

Cash screen not assessed — no interest-bearing-securities line and no sourced threshold.

Not assessed

Non-compliant income / revenue

Impure-income screen needs the company's filing — not assessed yet.

Not assessed

Receivables test

No receivables or total-assets field — not assessed.

Not assessed

Net debt / equity (context)10.2%

Measurable on 1 of 4 AAOIFI ratios; 3 not in this dataset.

Screening estimate, not a fatwa — we never pass a ratio without showing it. Verify with a qualified Shariah board.

Zakat estimator

Zakat due on a shareholding at today's price.

Zakat per share

0.1223 USD

Zakatable base / share

4.89 USD

Shares you hold

Zakat rate

Holding value

8,867 USD

Zakat due

12.23 USD

Long-term base uses cash & equivalents only (receivables and inventory are not in our data), so it understates zakat.

Zakat is due only after one full lunar year of ownership (hawl).

Estimate only, not a ZATCA filing — zakat on shares depends on intent (trading vs long-term). Consult a specialist.

Abbott Laboratories

Health Check

Price, corporate actions & news

Growth & profitability

Dividend return (if you buy today)if you buy today

Dividend history

Quarterly dividends & yield

Corporate actions

Valuation breakdown

Wealth simulator

Community Notes0

Shariah compliance

Zakat estimator